Absci Corp. (ABSI)
8.82
+0.02
(+0.23%)
USD |
NASDAQ |
Sep 04, 16:00
8.81
-0.01
(-0.11%)
After-Hours: 20:00
Absci SG&A Expense (TTM) : 35.28M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 35.28M |
| March 31, 2026 | 34.64M |
| December 31, 2025 | 35.06M |
| September 30, 2025 | 35.27M |
| June 30, 2025 | 36.08M |
| March 31, 2025 | 36.90M |
| December 31, 2024 | 36.17M |
| September 30, 2024 | 36.67M |
| June 30, 2024 | 36.92M |
| March 31, 2024 | 36.98M |
| December 31, 2023 | 37.83M |
| September 30, 2023 | 36.26M |
| June 30, 2023 | 38.16M |
| Date | Value |
|---|---|
| March 31, 2023 | 39.26M |
| December 31, 2022 | 40.55M |
| September 30, 2022 | 41.99M |
| June 30, 2022 | 40.31M |
| March 31, 2022 | 34.98M |
| December 31, 2021 | 28.78M |
| September 30, 2021 | 19.60M |
| June 30, 2021 | 11.12M |
| March 31, 2021 | 6.803M |
| December 31, 2020 | 3.089M |
| September 30, 2020 | 3.089M |
| June 30, 2020 | 1.832M |
| March 31, 2020 | 0.971M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Twist Bioscience Corp. | 290.29M |
| Prime Medicine, Inc. | 54.39M |
| Beam Therapeutics, Inc. | 125.40M |
| Tenax Therapeutics, Inc. | 23.36M |
| Exicure, Inc. | 5.28M |